Evidence map›Paper›PMID 18179991›Full record

Trial reportThe American journal of geriatric pharmacotherapy2007

Distribution and correlates of serum 25-hydroxyvitamin D levels in a sample of patients with hip fracture.

Carl F Pieper, Cathleen Colon-Emeric, John Caminis, Kathleen Betchyk, Jie Zhang, Cheri Janning, John Shostak, Meryl S LeBoff, Robert R Heaney, Kenneth W Lyles

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The American journal of geriatric pharmacotherapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 4 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 4 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. The effect of zoledronic acid and high-dose vitamin D on function after hip fractures. A prospective cohort study.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2022
    Article
  7. Article
  8. Review
  9. A rare complication after intertrochanteric fracture treated with proximal femoral nail: femoral neck insufficiency fracture.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2013
    Article
  10. Article
  11. Article
  12. Article
  13. Vitamin d and cardiovascular disease.Current treatment options in cardiovascular medicine · 2012
    Article
  14. How much vitamin D should I take?The Journal of clinical investigation · 2012
    Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Carl F PieperCenter on Aging and Human Development, Duke University Medical Center, Durham, North Carolina 27710, USA. carl.pieper@duke.edu
Cathleen Colon-Emeric
John Caminis
Kathleen Betchyk
Jie Zhang
Cheri Janning
John Shostak
Meryl S LeBoff
Robert R Heaney
Kenneth W Lyles
Duke Medical Center · USNovartis (United States) · USClinical Research Institute · USCreighton University · USHarvard University · US

Funding

Taste and smell enhancement in older cancer patientsP60AG011268 · NIA · DUKE UNIVERSITY · PI COHEN, HARVEY JAY · 1992 to 2005
$5.8M
Evidence-Based Medicine in the Skilled Nursing FacilityK23AG024787 · NIA · DUKE UNIVERSITY · PI COLON-EMERIC, CATHLEEN S · 2004 to 2008
$815k
NIA NIH HHS 3P60 AG11268-10S1NIA NIH HHS AG024787-01NIA NIH HHS K23 AG024787NIA NIH HHS P60 AG011268
6 · The paper itself

Abstract

backgroundVitamin D deficiency is common in older populations, particularly during the winter months due to low levels of ultraviolet light exposure, and in nursing home residents.

objectiveThe main objective of the current study was to assess the distribution of serum 25-hydroxyvitamin D and its correlates in a sample of men and women with recent hip fractures who were part of a large clinical trial.

methodsThis was a cross-sectional exploratory study of screened and ultimately randomized patients with hip fractures. They were part of a multinational (115 clinical centers in 20 countries), randomized, placebo-controlled, double-blind study testing the efficacy of a yearly IV bisphosphonate (zoledronic acid) in the prevention of new clinical fractures in patients with recent hip fracture repair. Levels of 25-hydroxyvitamin D, calcium, alkaline phosphatase, creatinine clearance, and albumin were measured at a screening visit using blood serum. Demographic variables were assessed by patient self-report. Bone mineral density (BMD) was assessed by dual-energy x-ray absorptiometry of the nonfractured hip.

resultsThis report included 1174 screened patients (526 with vitamin D measured) and 655 (385 with vitamin D measured) patients randomized before the protocol amendment. In screened patients, levels of 25-hydroxyvitamin D were low (median, 14.7 ng/mL; interquartilc range, 7.6, 21.65). Overall, 51% were at or below the clinically meaningful threshold of 15 ng/mL. Among those patients randomized, the level of 25-hydroxyvitamin D was significantly positively related to male sex (rho, 0.13; P < 0.05), serum calcium (rho, 0.16; P < 0.01), and BMD at the femoral neck (rho, 0.22; P < 0.01) in bivariate analyses. Low serum 25-hydroxyvitamin D (<15 ng/mL) was related only to low serum calcium (odds ratio, 0.16; 95% CI, 0.05-0.52) in multivariable logistic models controlling for sex, age, race, body mass index, living at home, alkaline phosphatase, and creatinine clearance.

conclusionsWe concluded that vitamin D insufficiency was a common problem in this population of elderly patients who had recently suffered a hip fracture. This insufficiency was related only to serum calcium in multivariable controlled models but cannot be reliably identified or excluded by measuring serum calcium alone. Physicians should be encouraged to check and monitor patients' serum levels of 25-hydroxyvitamin D.

Indexed as

Bone DensityHip FracturesAgedAged, 80 and overBone Density Conservation AgentsCalciumCross-Sectional StudiesDiphosphonatesDouble-Blind MethodFemaleFemur NeckHumansImidazolesLogistic ModelsMaleMultivariate Analysis25-hydroxyvitamin DBone Density Conservation AgentsCalciumDiphosphonatesImidazolesVitamin DZoledronic Acid

Identifiers

PMID18179991
PMCPMC2387201
OpenAlexW1984801145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.